Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Cai

Showing results (1061-1070 of 1,075) with videos related to

Pageof 108
Sort By:
Cell Genomics|February 15, 2024
Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediationMiao Xu, Ruimei Feng, Zhonghua Liu, et al.
Theranostics|December 8, 2025
Aggregation-induced emission of DNA fluorescence as a novel pan-marker of cell death, senescence and sepsis <i>in vitro</i> and <i>in vivo</i>Yiling Hu, Xiaoyan Wang, Ke Lu, et al.
Chinese Medical Journal|October 16, 2020
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasisLin Cai, Jian-Zhong Zhang, Xu Yao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Associations between variants of the 8q24 chromosome and nine smoking-related cancer sitesSungshim Lani Park, Shen-Chih Chang, Lin Cai, et al.
Chinese Medical Journal|November 12, 2020
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasisLin Cai, Gen-Hui Chen, Qian-Jin Lu, et al.
Chinese Medical Journal|September 25, 2024
Percutaneous coronary intervention vs . medical therapy in patients on dialysis with coronary artery disease in ChinaEnmin Xie, Yaxin Wu, Zixiang Ye, et al.
International Journal of Cancer|January 30, 2010
Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancersSam S Oh, Shen-Chih Chang, Lin Cai, et al.
The Journal of Clinical Investigation|November 26, 2024
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinomaXiang-Wei Kong, Guo-Long Bu, Hua Chen, et al.
Carcinogenesis|May 19, 2010
Associations between NBS1 polymorphisms, haplotypes and smoking-related cancersSungshim L Park, Delara Bastani, Binh Y Goldstein, et al.
The British Journal of Dermatology|February 17, 2024
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasisLin Cai, Congjun Jiang, Guoqiang Zhang, et al.
Pageof 108

Showing results (1061-1070 of 1,075) with videos related to

Sort By:
Pageof 108
Cell Genomics|February 15, 2024
Host genetic variants, Epstein-Barr virus subtypes, and the risk of nasopharyngeal carcinoma: Assessment of interaction and mediationMiao Xu, Ruimei Feng, Zhonghua Liu, et al.
Theranostics|December 8, 2025
Aggregation-induced emission of DNA fluorescence as a novel pan-marker of cell death, senescence and sepsis <i>in vitro</i> and <i>in vivo</i>Yiling Hu, Xiaoyan Wang, Ke Lu, et al.
Chinese Medical Journal|October 16, 2020
Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasisLin Cai, Jian-Zhong Zhang, Xu Yao, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 8, 2008
Associations between variants of the 8q24 chromosome and nine smoking-related cancer sitesSungshim Lani Park, Shen-Chih Chang, Lin Cai, et al.
Chinese Medical Journal|November 12, 2020
A double-blind, randomized, placebo- and positive-controlled phase III trial of 1% benvitimod cream in mild-to-moderate plaque psoriasisLin Cai, Gen-Hui Chen, Qian-Jin Lu, et al.
Chinese Medical Journal|September 25, 2024
Percutaneous coronary intervention vs . medical therapy in patients on dialysis with coronary artery disease in ChinaEnmin Xie, Yaxin Wu, Zixiang Ye, et al.
International Journal of Cancer|January 30, 2010
Single nucleotide polymorphisms of 8 inflammation-related genes and their associations with smoking-related cancersSam S Oh, Shen-Chih Chang, Lin Cai, et al.
The Journal of Clinical Investigation|November 26, 2024
A large-scale population-based study reveals that gp42-IgG antibody is protective against EBV-associated nasopharyngeal carcinomaXiang-Wei Kong, Guo-Long Bu, Hua Chen, et al.
Carcinogenesis|May 19, 2010
Associations between NBS1 polymorphisms, haplotypes and smoking-related cancersSungshim L Park, Delara Bastani, Binh Y Goldstein, et al.
The British Journal of Dermatology|February 17, 2024
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasisLin Cai, Congjun Jiang, Guoqiang Zhang, et al.
Pageof 108